Our data show that targeting a TCR to the TRAC locus and placing it under the transcriptional control of the endogenous regulatory network redirects the specificity of the modified T cells and enables them to specifically eliminate tumor cells in vitro and in a murine in vivo tumor xenograft model. This evidence concerns the gene TRAC and neoplasm.